Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02556918 · ClinicalTrials.gov registry record · Phase 4
Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery
A Phase 4 study of Hyperglycemia, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 202
- Enrollment target
- 3
- Study locations
NCT02556918 is a Phase 4 study of Hyperglycemia that has completed, run by Emory University. The registered enrollment target is 202 participants, below the 874-participant average among 38 other Hyperglycemia trials with a reported enrollment target (77% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT02556918, a Phase 4 study of Hyperglycemia, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 202 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to determine whether treatment with sitagliptin reduces the frequency and severity of high blood sugar (hyperglycemia) after cardiac surgery and to determine whether treatment with sitagliptin is effective in maintaining blood sugar control in patients with type 2 diabetes (T2D).
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Sitagliptin
- DRUG Insulin glargine
- DRUG Regular Human Insulin
- DRUG Supplemental insulin (Insulin lispro)
Study Locations (3)
Georgia
- Grady Health System - Atlanta
- Emory Univeristy Hospital Midtown - Atlanta
- Emory University Hospital - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2016-01 |
| Est. Completion | 2018-11-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02556918
The ClinicalTrials.gov registry entry for NCT02556918 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 202 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 874-participant average among 38 other Hyperglycemia trials with a reported enrollment target (77% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hyperglycemia appearing as the primary indexed condition, and to 5 interventions - of which Placebo is the first listed.
NCT02556918 reports 3 study locations spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT02556918 about?
NCT02556918 is a clinical study titled "Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery". The purpose of this study is to determine whether treatment with sitagliptin reduces the frequency and severity of high blood sugar (hyperglycemia) after cardiac surgery and to determine whether treatment with sitagliptin is effective in maintaining blood sugar control in patients with type 2 diabet...
What is the current status of trial NCT02556918?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 202 participants. The study started on 2016-01. Estimated completion is 2018-11-06.
What conditions does trial NCT02556918 study?
This clinical trial studies the following conditions: Hyperglycemia.
What interventions are being tested in trial NCT02556918?
The interventions under investigation include: Placebo (DRUG), Sitagliptin (DRUG), Insulin glargine (DRUG), Regular Human Insulin (DRUG), Supplemental insulin (Insulin lispro) (DRUG).
Who is sponsoring clinical trial NCT02556918?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02556918 being conducted?
This trial has 3 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperglycemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Zinc on Glucose Homeostasis
RECRUITING · Phase 4
-
The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients
COMPLETED · Phase 4
-
Diabetes in the Elderly: Prospective Study
COMPLETED · Phase 4
-
Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism
COMPLETED · Phase 4
-
Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy
COMPLETED · Phase 4
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.